blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2782914

EP2782914 - METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  07.06.2019
Database last updated on 23.04.2024
FormerThe patent has been granted
Status updated on  29.06.2018
FormerGrant of patent is intended
Status updated on  14.05.2018
FormerExamination is in progress
Status updated on  23.03.2018
FormerGrant of patent is intended
Status updated on  01.03.2018
FormerExamination is in progress
Status updated on  06.12.2016
Most recent event   Tooltip03.07.2020Lapse of the patent in a contracting state
New state(s): CY, MK
published on 05.08.2020  [2020/32]
Applicant(s)For all designated states
Adverio Pharma GmbH
Willy-Brandt-Platz 2
12529 Schönefeld / DE
[2015/09]
Former [2015/05]For all designated states
Bayer Intellectual Property GmbH
Alfred-Nobel-Str. 10
40789 Monheim am Rhein / DE
Former [2015/02]For all designated states
Bayer Pharma Aktiengesellschaft
Müllerstrasse 178
13353 Berlin / DE
For all designated states
Adverio Pharma GmbH
Willy-Brandt-Platz 2
12529 Schönefeld / DE
Former [2014/40]For all designated states
Bayer Pharma Aktiengesellschaft
Müllerstrasse 178
13353 Berlin / DE
For all designated states
Bayer Intellectual Property GmbH
Alfred-Nobel-Strasse 10
40789 Monheim / DE
Inventor(s)01 / FEY, Peter
Am Eickhof 23
42111 Wuppertal / DE
02 / GRUNENBERG, Alfons
Bismarckstr. 87
42115 Wuppertal / DE
03 / BIERER, Donald
Horst 9
42781 Haan / DE
 [2015/48]
Former [2014/40]01 / FEY, Peter
Am Eickhof 23
42111 Wuppertal / DE
Representative(s)BIP Patents
c/o Bayer Intellectual Property GmbH
Alfred-Nobel-Straße 50
40789 Monheim am Rhein / DE
[N/P]
Former [2018/31]BIP Patents
c/o Bayer Intellectual Property GmbH
Alfred-Nobel-Straße 10
40789 Monheim am Rhein / DE
Former [2014/40]BIP Patents
c/o Bayer Intellectual Property GmbH
Creative Campus Monheim
Alfred-Nobel-Straße 10
40789 Monheim / DE
Application number, filing date12790891.121.11.2012
[2018/31]
WO2012EP73276
Priority number, dateEP2011019078925.11.2011         Original published format: EP 11190789
EP2011019230107.12.2011         Original published format: EP 11192301
[2014/40]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO2013076168
Date:30.05.2013
Language:DE
[2013/22]
Type: A1 Application with search report 
No.:EP2782914
Date:01.10.2014
Language:DE
The application published by WIPO in one of the EPO official languages on 30.05.2013 takes the place of the publication of the European patent application.
[2014/40]
Type: B1 Patent specification 
No.:EP2782914
Date:01.08.2018
Language:DE
[2018/31]
Search report(s)International search report - published on:EP30.05.2013
ClassificationIPC:C07D471/04, A61K31/506, A61P9/00
[2014/40]
CPC:
A61P9/00 (EP,IL,KR,US); C07D295/104 (IL,KR,US); C07D471/04 (EP,CN,IL,KR,US);
A61K31/506 (KR); C07C303/28 (IL,KR,US); C07C309/04 (IL,US);
C07C309/65 (IL); C07C317/04 (IL,KR,US); C07D265/30 (IL,KR,US);
C07D295/023 (CN); C07D295/03 (CN); C07D295/037 (CN);
C07D295/067 (CN,IL,KR,US); C07B2200/13 (CN,IL,KR,US) (-)
C-Set:
C07C303/28, C07C309/65 (US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/40]
Extension statesBA25.06.2014
ME25.06.2014
TitleGerman:VERFAHREN ZUR HERSTELLUNG VON SUBSTITUIERTEN 5-FLUOR-1H-PYRAZOLOPYRIDINEN[2014/40]
English:METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES[2014/40]
French:PROCÉDÉ DE PRODUCTION DE 5-FLUORO-1H-PYRAZOLOPYRIDINES SUBSTITUÉES[2014/40]
Entry into regional phase25.06.2014National basic fee paid 
25.06.2014Designation fee(s) paid 
25.06.2014Examination fee paid 
Examination procedure25.06.2014Examination requested  [2014/40]
19.01.2015Amendment by applicant (claims and/or description)
28.04.2015Despatch of a communication from the examining division (Time limit: M06)
07.12.2015Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
26.01.2016Reply to a communication from the examining division
02.05.2016Despatch of a communication from the examining division (Time limit: M04)
30.08.2016Reply to a communication from the examining division
25.11.2016Despatch of a communication from the examining division (Time limit: M04)
30.03.2017Reply to a communication from the examining division
28.07.2017Despatch of a communication from the examining division (Time limit: M02)
28.09.2017Reply to a communication from the examining division
02.03.2018Communication of intention to grant the patent
14.03.2018Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
15.05.2018Communication of intention to grant the patent
20.06.2018Fee for grant paid
20.06.2018Fee for publishing/printing paid
20.06.2018Receipt of the translation of the claim(s)
Divisional application(s)EP15151593.9  / EP2896617
EP18178621.1  / EP3421470
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  28.04.2015
Opposition(s)03.05.2019No opposition filed within time limit [2019/28]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
26.01.2016Request for further processing filed
26.01.2016Full payment received (date of receipt of payment)
Request granted
10.02.2016Decision despatched
Fees paidRenewal fee
10.11.2014Renewal fee patent year 03
10.11.2015Renewal fee patent year 04
10.11.2016Renewal fee patent year 05
13.11.2017Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL01.08.2018
CY01.08.2018
MC01.08.2018
MK01.08.2018
SM01.08.2018
GR02.11.2018
LU21.11.2018
[2020/31]
Former [2019/34]AL01.08.2018
MC01.08.2018
SM01.08.2018
GR02.11.2018
LU21.11.2018
Former [2019/33]AL01.08.2018
MC01.08.2018
SM01.08.2018
GR02.11.2018
Former [2019/26]AL01.08.2018
SM01.08.2018
GR02.11.2018
Former [2019/13]AL01.08.2018
GR02.11.2018
Former [2019/11]GR02.11.2018
Cited inInternational search[AD]WO03095451  (BAYER AG [DE], et al) [AD] 1-3,6-24 * examples 5,7A,8A; claims 1,4-6,10 *;
 [IDP]WO2011147809  (BAYER PHARMA AG [DE], et al) [IDP] 10-19 * page 1, paragraph 1; examples 6A-11A,1; claims 1,4-11 *;
 [IP]WO2012028647  (BAYER PHARMA AG [DE], et al) [IP] 10-19* page 1, paragraph 1; examples 25A-31A; claims 1,6-12; table 2 *
ExaminationWO2011064156
by applicantWO0006569
 WO03004503
 WO03095451
 WO2009018415
 WO2011064156
 WO2011064171
 WO2011147809
    - L.F.CAVALIERI; J.F.TANKER; A.BENDICH, J.AM.CHEM.SOC., (1949), vol. 71, page 533
    - YAMANAKA, S. YAMASHITA; T. ISHIHARA, SYNLETT, (1993), pages 353 - 354
    - H. YAMANAKA; M.KUWABARA; M. OKUDO; K. FUKUNISHI; M. NOMURA, NIPPON KAGAKU KAISHI, (1985), pages 1988 - 1994
    - H. YAMANAKA; H. GANBAYASHI; M.KUWABARA; K. FUKUNISHI; M. NOMURA, NIPPON KAGAKU KAISHI, (1988), pages 1036 - 1043
    - H. YAMANAKA; S. YAMASHITA; T. ISHIHARA, SYNLETT, (1993), pages 353 - 354
    - MARKOVSKII, L. N.; KOLESNIK, N. P.; SHERMOLOVICH, YU, G ZHURNAL OBSHCHEI KHIMII, (1980), vol. 50, no. 4, pages 826 - 829
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.